Biljan, M M <br/><br/>
Pretreatment with an oral contraceptive is effective in reducing the incidence of functional ovarian cyst formation during pituitary suppression by gonadotropin-releasing hormone analogues.  [electronic resource] 

 -  Journal of assisted reproduction and genetics  Nov 1998 
 - 599-604 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article 
<br/><br/><label>ISSN: </label>1058-0468 
<br/><br/><label>Standard No.: </label>10.1023/a:1020381310860  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Buserelin--adverse effects<br/>Case-Control Studies<br/>Desogestrel--administration & dosage<br/>Estradiol Congeners--administration & dosage<br/>Ethinyl Estradiol--administration & dosage<br/>Female<br/>Fertility Agents, Female--adverse effects<br/>Fertilization in Vitro<br/>Follicle Stimulating Hormone--metabolism<br/>Gonadotropin-Releasing Hormone--agonists<br/>Humans<br/>Luteinizing Hormone--metabolism<br/>Menotropins--therapeutic use<br/>Ovarian Cysts--chemically induced<br/>Ovarian Follicle--growth & development<br/>Ovulation Induction<br/>Pituitary Gland, Anterior--drug effects<br/>Pregnancy<br/>Pregnancy Rate<br/>Premedication<br/>Progesterone Congeners--administration & dosage<br/>Retrospective Studies<br/>Secretory Rate--drug effects